论文部分内容阅读
目的探讨小儿肺炎采用布地奈德雾化吸入治疗的临床疗效与应用价值。方法选取宝鸡市妇幼保健院2015年2月至2015年10月收治的肺炎患儿68例,依据数字表法分为对照组与观察组,各组患儿均为34例,其中对照组均采用常规治疗,观察组均采用常规治疗+布地奈德雾化吸入治疗,对比分析两种不同治疗方法的临床应用效果。结果观察组患儿治疗总有效率为97.1%。对照组患儿治疗总有效率为85.3%,两组患儿治疗总有效率比较差异存在统计学意义(P<0.05)。治疗后,观察组患儿咳嗽、气喘等临床症状缓解时间、退热时间与住院时间等均短于照组(P<0.05),数据比较统计学意义显著。结论采用布地奈德雾化吸入治疗小儿肺炎,患儿咳嗽、气喘等各项临床症状缓解较快,退热时间和住院时间均较短,治疗效果显著,具有较高的临床推广价值。
Objective To investigate the clinical efficacy and value of inhalation of budesonide inhalation for pediatric pneumonia. Methods 68 cases of children with pneumonia admitted from February 2015 to October 2015 in Baoji Maternal and Child Health Hospital were divided into control group and observation group according to the digital table method, with 34 cases in each group, of which the control group Routine treatment and observation group were treated with routine therapy + budesonide inhalation therapy, comparative analysis of the clinical effects of two different treatment methods. Results The total effective rate of treatment group was 97.1%. The total effective rate of treatment children was 85.3%. There was significant difference between the two groups in the total effective rate of treatment (P <0.05). After treatment, the clinical symptoms such as cough and asthma in the observation group were shorter than those in the control group (P <0.05), and the data were statistically significant. Conclusion The inhalation of budesonide for treatment of pneumonia in children, children with cough, asthma and other clinical symptoms alleviate faster, fever and hospitalization time are shorter, the treatment effect is significant, with high clinical value.